Eyenovia, a company focused on eye care technology, just made a big move. It raised $50 million through a private sale to investors. The fund will help Eyenovia buy over one million HYPE tokens.
Advertisement
Advertisement
Eyenovia Blends Eye Care Innovation with Web3
Each token of the native currency of the Hyperliquid blockchain will cost about $34. This makes Eyenovia the first US public company listed on Nasdaq to hold such a large amount of HYPE and run a validator, a system that helps keep the Hyperliquid network running smoothly.
The company is also working on a new eye care device called the Optejet User Filled Device. This tool makes it easier to apply eye drops for issues like dry eyes or contact lens care. Eyenovia plans to register this device with the FDA by September 2025. They are already talking to other companies about partnering to sell this product.
Eyenovia’s CEO, Michael Rowe, said this funding is a step toward blending eye care innovation with digital currency. The company believes HYPE tokens will grow in value as more people use the Hyperliquid platform. By holding these tokens and running a validator, Eyenovia aims to create extra value for its investors.
Advertisement
Advertisement
Eyenovia Eyes Rebrand as HYPE Investment Strategy Expands
After purchasing $50 million worth of HYPE last week, the company announced that it might soon change its name. It plans to change its name to Hyperion DeFi and its stock ticker to HYPD. The change marks its new focus on both eye care and digital finance.
Eyenovia’s move into this space offers its investors a way to benefit from this growing digital economy. Meanwhile, the Optejet device is moving forward. Next month, Eyenovia will start testing to ensure it works well.
This device could make eye treatments easier and safer, helping people stick to their care routines. Eyenovia is balancing its eye care goals with this new digital currency strategy, aiming to lead in both fields.
Like Eyenovia, Lion Group Holding, a Singapore-based trading platform also raised $600 million to create a HYPE treasury. HYPE token has surged to $35.29, marking a 8.47% increase over the past day. Daily trading volume reached $432 million, up 8.26% from previous levels.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Eyenovia Closes $50M Private Placement for HYPE Treasury
Eyenovia, a company focused on eye care technology, just made a big move. It raised $50 million through a private sale to investors. The fund will help Eyenovia buy over one million HYPE tokens.
Advertisement
Advertisement
Eyenovia Blends Eye Care Innovation with Web3
Each token of the native currency of the Hyperliquid blockchain will cost about $34. This makes Eyenovia the first US public company listed on Nasdaq to hold such a large amount of HYPE and run a validator, a system that helps keep the Hyperliquid network running smoothly.
The company is also working on a new eye care device called the Optejet User Filled Device. This tool makes it easier to apply eye drops for issues like dry eyes or contact lens care. Eyenovia plans to register this device with the FDA by September 2025. They are already talking to other companies about partnering to sell this product.
Eyenovia’s CEO, Michael Rowe, said this funding is a step toward blending eye care innovation with digital currency. The company believes HYPE tokens will grow in value as more people use the Hyperliquid platform. By holding these tokens and running a validator, Eyenovia aims to create extra value for its investors.
Advertisement
Advertisement
Eyenovia Eyes Rebrand as HYPE Investment Strategy Expands
After purchasing $50 million worth of HYPE last week, the company announced that it might soon change its name. It plans to change its name to Hyperion DeFi and its stock ticker to HYPD. The change marks its new focus on both eye care and digital finance.
Eyenovia’s move into this space offers its investors a way to benefit from this growing digital economy. Meanwhile, the Optejet device is moving forward. Next month, Eyenovia will start testing to ensure it works well.
This device could make eye treatments easier and safer, helping people stick to their care routines. Eyenovia is balancing its eye care goals with this new digital currency strategy, aiming to lead in both fields.
Like Eyenovia, Lion Group Holding, a Singapore-based trading platform also raised $600 million to create a HYPE treasury. HYPE token has surged to $35.29, marking a 8.47% increase over the past day. Daily trading volume reached $432 million, up 8.26% from previous levels.
Advertisement
✓ Share:
